Home > Insider Trading > Filing (0000899243-19-029139)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1157601	Madrigal Pharmaceuticals Inc.	MDGL	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1288452	Bay City Capital Llc	750 Battery Street, Suite 400 San Francisco CA 94111	No	No	Yes	No
1333817	Bay City Capital Fund Iv Co Invesment Fund Lp	750 Battery Street, Suite 400 San Francisco CA 94111	No	No	Yes	No
1359070	Bay City Capital Management Iv Llc	750 Battery Street, Suite 400 San Francisco CA 94111	No	No	Yes	No
1360243	Bay City Capital Fund Iv, L.p.	750 Battery Street, Suite 400 San Francisco CA 94111	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-12-13	1,174,680	$105.47	4,089,702	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2019-12-13	25,320	$105.47	88,152	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Footnotes

Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV.
The securities are held by Fund IV.
The securities are held by Co-Investment IV.